Valuation: Ind-Swift Laboratories Limited

Market Cap 11.4B 118M 103M 96.12M 88.29M 166M 169M 1.14B 447M 5.57B 443M 433M 19.26B P/E 2024
1.41x
P/E 2025 2.38x
Enterprise Value 7.13B 73.86M 64.73M 60.14M 55.24M 104M 106M 716M 280M 3.49B 277M 271M 12.05B EV / Sales 2024
0.14x
EV / Sales 2025 0.12x
Free-Float
40.72%
Yield 2024 *
-
Yield 2025 -
1 day-1.91%
1 week+1.40%
Current month+14.51%
1 month+24.38%
3 months+61.92%
6 months+119.30%
Current year+164.40%
1 week 224
Extreme 224
240.39
1 month 189.31
Extreme 189.31
248.45
Current year 87.25
Extreme 87.25
248.45
1 year 87.15
Extreme 87.15
248.45
3 years 68.72
Extreme 68.72
248.45
5 years 52.65
Extreme 52.65
248.45
10 years 15
Extreme 15
248.45
Manager TitleAgeSince
Chief Executive Officer 74 1995-01-03
Chief Executive Officer 43 2011-06-14
Director of Finance/CFO - 2018-09-28
Director TitleAgeSince
Director/Board Member 43 -
Chairman 74 -
Director/Board Member 35 2010-03-22
Date Insider Type Main position Quantity % Market Cap.
9/12/24 Sell

Chief Financial Officer

30,000 0.0508%
Change 5-day change 1-year change 3-year change Capi.($)
-1.91%+1.40%+119.86%+153.47% 214M
-0.96%+0.02%+14.81%+77.10% 48.88B
-0.99%-0.27%+66.69%+108.95% 35.72B
-1.21%-1.60%-3.99%+34.91% 12.02B
-1.47%-0.64%+16.11%+83.68% 11.84B
-0.37%+0.94%+34.42%+136.73% 8.95B
+0.33%-1.13%+50.36%-5.96% 6.91B
-0.34%-2.41%+14.20%+33.03% 6.78B
-1.88%-4.56%+0.69%+192.09% 6.57B
-2.47%-5.28%-33.67%+6.76% 5.81B
Average -1.13%-1.66%+27.95%+82.08% 14.37B
Weighted average by Cap. -1.01%-0.35%+26.70%+82.20%

Financials

2024 2025
Net sales 12.97B 134M 118M 109M 100M 189M 192M 1.3B 509M 6.34B 504M 493M 21.92B 5.62B 58.18M 50.99M 47.37M 43.52M 81.97M 83.25M 564M 220M 2.75B 218M 214M 9.49B
Net income 4.21B 43.6M 38.21M 35.5M 32.61M 61.43M 62.39M 423M 165M 2.06B 164M 160M 7.11B 2.5B 25.94M 22.74M 21.13M 19.4M 36.55M 37.12M 251M 98.32M 1.22B 97.38M 95.27M 4.23B
Net Debt -4.15B -43.01M -37.7M -35.03M -32.17M -60.61M -61.55M -417M -163M -2.03B -161M -158M -7.02B -4.27B -44.18M -38.72M -35.98M -33.04M -62.25M -63.21M -428M -167M -2.08B -166M -162M -7.21B
Logo Ind-Swift Laboratories Limited
Ind-Swift Laboratories Limited is an India-based company, which is engaged in the business of manufacturing active pharmaceutical ingredients (APIs), intermediates and formulations. The Company operates in the Pharmaceutical Business segment. It also focuses on manufacturing formulations. The Company’s products include APIs and Impurities. Its APIs therapeutic category includes Macrolide Antibiotic, Cardiovascular, Antihistaminic, Antidiabetic, Antipsyhotic, Bone Resorption Inhibitor, and Aromatase Inhibitor. Its products include Clarithromycin, Clarithromycin Coated Granules, Clarithromycin Citrate, Atorvastatin Calcium Crystalline, Atorvastatin Calcium Amorphous, Clopidogrel HCl, Ezetimibe, Ivabradine Oxalate, Ranolazine, Aripiprazole, Risedronate Sodium, Ropinirole HCl, Cinacalcet HCl, Letrozole, and Anastrozole. Its products under development include Sitagliptin Phosphate, Mirabegron, Bempedoic Acid, Lasmiditan, and Eltrombopag Olamine.
Employees
1,246
Date Price Change Volume
26-07-22 ₹233.07 -1.91% 447,639
26-07-21 ₹237.60 +1.54% 271,232
26-07-20 ₹233.99 +1.09% 438,766
26-07-17 ₹231.47 -1.03% 288,534
26-07-16 ₹233.89 +3.12% 562,319
  1. Stock Market
  2. Stocks
  3. INDSWFTLAB Stock